Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy

Abstract Background Corticosteroids are routinely utilized to alleviate edema in patients with intracranial lesions and are first-line agents to combat immune-related adverse events (irAEs) that arise with immune checkpoint blockade treatment. However, it is not known if or when corticosteroids can...

Cijeli opis

Bibliografski detalji

Glavni autori:	Amber J. Giles, Marsha-Kay N. D. Hutchinson, Heather M. Sonnemann, Jinkyu Jung, Peter E. Fecci, Nivedita M. Ratnam, Wei Zhang, Hua Song, Rolanda Bailey, Dionne Davis, Caitlin M. Reid, Deric M. Park, Mark R. Gilbert
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 2018-06-01
Serija:	Journal for ImmunoTherapy of Cancer
Teme:	Corticosteroids Immunotherapy Glioma Checkpoint blockade Dexamethasone
Online pristup:	http://link.springer.com/article/10.1186/s40425-018-0371-5
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!